Диссертация (1174231), страница 21
Текст из файла (страница 21)
— Р. 461–472.57. Chronic lithium chloride administration attenuates brain NMDA receptor-initiatedsignaling via arachidonic acid in unanesthetized rats / M. Basselin, L. Chang,J. M. Bell, S. I. Rapoport // Neuropsychopharmacol. — 2006. — Vol. 31(8). —Р. 1659–1674.14058. Chronic lithium treatment increases the expression of brain-derived neurotrophicfactor in the rat brain / T. Fukumoto [et al.] // Psychopharmacology.
— 2001. —Vol. 158(1). — Р. 100–106.59. Chronic treatment with a low dose of lithium protects the brain against ischemicinjury by reducing apoptotic death / J. Xu [et al.] // Stroke. — 2003. —Vol. 34(5). — Р. 1287–1292.60. Chuang, D. M. GSK-3 as a target for lithium-induced neuroprotection againstexcitotoxicity in neuronal cultures and animal models of ischemic stroke / D. M.Chuang, Z. Wang, C. T. Chiu // Front Mol .Neurosci. — 2011.
— Vol. 4. —Р. 15.61. Chuang, D. M. Potential use of lithium in neurodegenerative disorders / D. M.Chuang, J. Priller // Lithium in Neuropsychiatry: The Comprehensive Guide /ed. by M. Bauer, P. Grof, B. Muller-Oerlinghausen. — Abingdon, Oxon : InformaUK Ltd, 2006. — Р.
381–398.62. Combined lithium and valproate treatment delays disease onset, reduces neurological deficits and prolongs survival in an amyotrophic lateral sclerosis mousemodel / H. L. Feng [et al.] // Neuroscience. — 2008. — Vol. 155(3). — Р. 567–572.63. Common effects of lithium and valproate on mitochondrial functions: protectionagainst methamphetamine-induced mitochondrial damage / R. F.
Bachmann[et al.] // Int. J. Neuropsychopharmacol. — 2009. — Vol. 12(6). — Р. 805–822.64. Concurrent administration of Neu2000 and lithium produces marked improvement of motor neuron survival, motor function, and mortality in a mouse model ofamyotrophic lateral sclerosis / J. H. Shin [et al.] / Mol. Pharmacol. — 2007. —Vol. 71(4). — Р. 965–975.65.
Corticostriatal dysfunction underlies diminished striatal ascorbate release in theR6/2 mouse model of huntington’s disease / J. L. Dorner [et al.] // Brain Res. —2009. — Vol. 1290. — Р. 111–120.14166. Cross-sectional and longitudinal relationship of sodium-lithium countertransportto insulin, obesity and blood pressure in healthy perimenopausal women /C. H. Bunker [et al.] // J. Hum Hypertens. — 1991. — Vol. 5(5). — Р.
381–392.67. Curran, G. Lithium for bipolar disorder: A review of the recent literature / G. Curran, A. Ravindran // Expert Rev. Neurother. — 2014. — Vol. 14. — Р. 1079–1098.68. De Munter, J. P. J. M. Stem cell grafting in parkinsonism — Why, how andwhen / J. P.
J. M. De Munter, E. Melamed, E. C. Wolters // Parkinsonism and Related Disorders. — 2014. — Vol. 20S1. — Р. 150–153.69. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolarpatients during manic episode / R. Machado-Vieira [et al.] // Biol. Psychiatry. —2007. — Vol. 61(2). — Р. 142–144.70. Decreased plasma levels of brain-derived neurotrophic factor (BDNF) duringmixed episodes of bipolar disorder / A. Piccinni [et al.] // J. Affect Disord.
—2015. — Vol. 171. — Р. 167–170.71. Dementia prevention, intervention, and care / G. Livingston [et al.] // Lancet. —2017. — Jul 19. — Р. 0140–6736(17).72. Dietary intake of antioxidants and risk of Alzheimer disease / M. J. Engelhart[et al.] // J. Am. Med. Assoc. — 2002. — Vol. 287(24). — Р. 3223–3229.73. Differential effect of lithium on cell number in the hippocampus and prefrontalcortex in adult mice: A stereological study / G. Rajkowska [et al.] // BipolarDisord.
— 2016. — Vol. 18. — Р. 41–51.74. Diniz, B. S. Lithium and neuroprotection: translational evidence and implicationsfor the treatment of neuropsychiatric disorders / B. S. Diniz, R. Machado-Vieira,O. V. Forlenza // Neuropsychiatr. Dis. Treat. — 2013. — Vol. 9. — Р. 493–500.75. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling / Y. Mao [et al.] // Cell. — 2009. —Vol.
136(6). — Р. 1017–1031.76. Doble, B. W. GSK-3: tricks of the trade for a multi-tasking kinase / B. W. Doble,J. R. Woodgett // J. Cell. Sci. — 2003. — Vol. 116(7). — Р. 1175–1186.14277. Dwivedi, T. Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptoticregulatory proteins / T. Dwivedi, H.
Zhang // Front Neurosci. — 2015. —Vol. 8. — Р. 457.78. Dynamics of hippocampal acetylcholine release during lithium-pilocarpineinduced status epilepticus in rats / M. H. Hillert [et al.] // J. Neurochem. —2014. — Vol. 131(1). — Р. 42–52.79.
Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacologicalinterventions / R. Heumann [et al.] // J. Neurochem. — 2014. — Vol. 130(4). —Р. 472–489.80. Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and oncell survival and proliferation / J. M. Aubry, M. Schwald, E.
Ballmann, F.Karege // Psychopharmacology (Berl). — 2009. — Vol. 205(3). — Р. 419–429.81. Effectiveness of maintenance therapy of lithium vs other mood stabilizers inmonotherapy and in combinations: A systematic review of evidence from observational studies / L. V. Kessing [et al.] // Bipolar Disorders.
— 2018. —Vol. 20. — Р. 419–431.82. Effects of lipids in patients with familial hypercholesterolaemia on the kinetics ofthe sodium-lithium countertransporter / A. S. Wierzbicki [et al.] // J. Hum.Hypertens. — 2000. — Vol. 14(9). — Р. 561–565.83. Effects of lithium on brain glucose metabolism in healthy men / T. Kohno [etal.] // J. Clin. Psychopharmacol.
— 2007. — Vol. 27(6). — Р. 698–702.84. Effects of lithium on oxidative stress and behavioral alterations inducedby lisdexamfetamine dimesylate: Relevance as an animal model of mania /D. S. Macedo [et al.] // Prog. Neuropsychopharmacol. Biol. Psychiatry. — 2013.— Vol. 43. — Р. 230–237.85. Effects of lithium on peripheral neuropathy induced by vincristine in rats / H.Alimoradi [et al.] // Acta Med. Iran. — 2012. — Vol. 50(6). — Р.
373–379.86. Effectsoflithiumontheactivitiesofphosphofructokinaseandphosphoglucomutase and on glucose-1,6-diphosphate levels in rat muscles, brain143and liver / J. Nordenberg [et al.] / Biochem. Pharmacol. 1982 — Vol. 31(6). — Р.1025–1031.87. Ellis, J. Chronic lithium treatment prevents atropine-induced supersensitivity ofthe muscarinic phosphoinositide response in rat hippocampus / J.
Ellis, R. H. Lenox // Biol. Psychiatry. 1990. — Vol. 28(7). — Р. 609–619.88. Emamghoreishi, M. Acute and chronic effects of lithium on BDNF and GDNFmRNA and protein levels in rat primary neuronal, astroglial and neuroastrogliacultures / M. Emamghoreishi, M. Keshavarz, A. A. Nekooeian // Iran. J. BasicMed. Sci. — 2015. — Vol. 18. — Р. 240–246.89. Enhanced tau phosphorylation in the hippocampus of mice treated with3,4-methylenedioxymethamphetamine / C. L. Busceti [et al.] // J.
Neurosci. —2008. — Vol. 28. — Р. 3234–3245.90. Erythrocyte sodium-lithium counter transport activity is inversely correlatedto adiponectin, retinol binding protein 4 and body height / E. Elias [et al.] //Scand. J. Clin. Lab. Invest. — 2010. — Vol. 70(7). — Р. 487–491.91. Erythrocyte sodium-lithium countertransport in insulin-dependent diabetics: correlation with membrane lipids, prorenin and micro-albuminuria / P. Lijnen [etal.] // J.
Hypertens Suppl. — 1993. — Vol. 11(5). — Р. 258–259.92. Evidence for selective microRNAs and their effectors as common long-term targetsfortheactionsofmoodstabilizers /R.Zhou[etal.] //Neuropsychopharmacology. — 2009. — Vol. 34(6). — Р. 1395–1405.93. Evidence that lithium protects against tardive dyskinesia: the Curacao Extrapyramidal syndromes study VI / P.
N. van Harten, H. W. Hoek, G. E. Matroos,van O. J. // Eur. Neuropsychopharmacol. — 2008. — Vol. 18. — Р. 152–155.94. FDG-PET study in pathological gamblers. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism / E. Hollander [et al.] // Neuropsychobiology. —2008. — Vol. 58(1). — Р. 37–47.95. Ferreira, A. J. M. MATLAB Codes for Finite Element Analysis. Springer [Electronic resource] / A. J.
M Ferreira. — URL: http://www.mathworks.com/products/simbiology/14496. Fontela, T. Role of adrenoceptors in vitro and in vivo in the effects of lithium onblood glucose levels and insulin secretion in the rat / T. Fontela, O. Garcia Hermida,J. Gomez-Acebo // Br. J. Pharmacol. — 1990. — Vol. 100(2). — Р. 283–288.97. Forlenza, O. V. Neuroprotective Effects of Lithium: Implications for the Treatment of Alzheimer’s Disease and Related Neurodegenerative Disorders /O. V.
Forlenza, V. J. De-Paula, B. S. Diniz. — ACS Chem. Neurosci, 2014.98. Fruit and Vegetable Intake and Risk of Amyotrophic Lateral Sclerosis in Japan /K. Okamoto [et al.] // Neuroepidemiology. — 2009. — Vol. 32(4). — Р. 251–256.99. Functional MRI of delayed chronic lithium treatment in rat focal cerebral ischemia / Y. R. Kim [et al.] // Stroke. — 2008. — Vol. 39(2). — Р. 439–447.100. Geddes, J. R.
Treatment of bipolar disorder / J. R. Geddes, D. J. Miklowitz // Lancet. — 2013. — Vol. 381. — Р. 1672–1682.101. Genetics of Alzheimer disease / M. L. Bekris [et al.] // J. Geriatr. PsychiatryNeurol. — 2010. — Vol. 23. — Р. 213–227.102. Ghasemzadeh, B. Dynamic changes in extracellular fluid ascorbic acid monitoredby in vivo electrochemistry / B.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
